Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • airtime
    Member
    • Jan 2011
    • 14

    #1

    Exome Sequencing with nimblegen SeqCap EZ v3

    Hi,

    we working with a GAllx from Illumina and have good experience with nimblegen SeqCap EZ v2 (on target).
    We compare the nimblegen SeqCap EZ v3 and Illumina TrueSeq exome kits and the results shocked me .
    For nimblegen we have nice mapping rate and low duplication level, but on target it is only 30 %.
    For illumina mapping is well but duplicate level is high (20 - 30 %). On target we can reach 76 %.

    How it could be that the on target of nimblen v3 kit is so bad? We have good results in the pre steps and everything looks similar to nimblegen v2.

    About hints or sharing experience about the nimblegen v3 kit I would be very lucky.
  • josdegraaf
    Member
    • Mar 2010
    • 33

    #2
    What do you call on target?

    Comment

    • airtime
      Member
      • Jan 2011
      • 14

      #3
      Hi,

      there are design files (.bed) with region information. And that reads mapped to the genome, including a region from the design file too, are on target.

      Comment

      • josdegraaf
        Member
        • Mar 2010
        • 33

        #4
        I know but some people take +- 100 or 200 bases as on target and some don't. Anyway 30% is very low, should be more towards >95% bases covered. We also used V3 and had +- 98%. Illumina performs slightly less with +- 92%.
        How deep did you sequence?

        Comment

        • airtime
          Member
          • Jan 2011
          • 14

          #5
          Hi,

          we used this desing file "SeqCap_EZ_Exome_v3_capture.bed" it include +- 100bp.
          how deep means how many reads we get out or how many mapped?

          Comment

          • airtime
            Member
            • Jan 2011
            • 14

            #6
            Hi,

            what you mentioned that 95% of bases are called means the uniformity.
            But the issue is that we mapped >90% of 100 000 000 reads to the genome and then we calculate the 30% on target amount (after duplication removement).

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 11:13 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 10:48 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Working...